JPMorgan Chase & Co. grew its stake in shares of Maiden Holdings, Ltd. (NASDAQ:MHLD - Free Report) by 145.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 331,368 shares of the insurance provider's stock after purchasing an additional 196,216 shares during the period. JPMorgan Chase & Co. owned approximately 0.33% of Maiden worth $560,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of MHLD. SG Americas Securities LLC increased its holdings in Maiden by 58.5% in the 4th quarter. SG Americas Securities LLC now owns 46,096 shares of the insurance provider's stock worth $78,000 after buying an additional 17,017 shares in the last quarter. State Street Corp boosted its holdings in shares of Maiden by 0.5% in the third quarter. State Street Corp now owns 1,201,024 shares of the insurance provider's stock worth $2,126,000 after buying an additional 6,341 shares during the last quarter. Barclays PLC grew its position in shares of Maiden by 268.8% during the 3rd quarter. Barclays PLC now owns 115,740 shares of the insurance provider's stock valued at $205,000 after acquiring an additional 84,359 shares during the period. Raymond James Financial Inc. purchased a new stake in Maiden in the fourth quarter worth about $35,000. Finally, Sowell Financial Services LLC raised its stake in Maiden by 29.9% during the 4th quarter. Sowell Financial Services LLC now owns 466,164 shares of the insurance provider's stock worth $788,000 after acquiring an additional 107,279 shares during the period. 21.78% of the stock is currently owned by hedge funds and other institutional investors.
Maiden Price Performance
Maiden stock traded down $0.05 during midday trading on Tuesday, reaching $1.24. 116,213 shares of the stock traded hands, compared to its average volume of 136,429. The stock has a market cap of $123.37 million, a P/E ratio of -1.91 and a beta of 1.31. Maiden Holdings, Ltd. has a 12 month low of $0.55 and a 12 month high of $2.26. The stock's fifty day moving average is $0.90 and its 200-day moving average is $1.19. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 1.22.
Maiden (NASDAQ:MHLD - Get Free Report) last announced its quarterly earnings results on Monday, March 10th. The insurance provider reported ($1.53) EPS for the quarter. Maiden had a negative net margin of 71.58% and a negative return on equity of 16.55%. The business had revenue of ($6.64) million during the quarter.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Maiden in a research note on Wednesday, April 16th. They issued a "sell" rating for the company.
Check Out Our Latest Research Report on Maiden
Maiden Company Profile
(
Free Report)
Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty insurance and reinsurance solutions to regional and specialty insurers in Europe, North America, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis.
Featured Stories

Before you consider Maiden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maiden wasn't on the list.
While Maiden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.